1. Neuroscience

Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish

  1. Chanpreet Singh
  2. Grigorios Oikonomou
  3. David A Prober  Is a corresponding author
  1. California Institute of Technology, United States
https://doi.org/10.7554/eLife.07000
Share this article
Cite this article
  1. Chanpreet Singh
  2. Grigorios Oikonomou
  3. David A Prober
(2015)
Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish
eLife 4:e07000.
https://doi.org/10.7554/eLife.07000
  2. Download BibTeX
  3. Download .RIS

Abstract

Pharmacological studies in mammals suggest that norepinephrine (NE) plays an important role in promoting arousal. However, the role of endogenous NE is unclear, with contradicting reports concerning the sleep phenotypes of mice lacking NE due to mutation of dopamine β-hydroxylase (dbh). To investigate NE function in an alternative vertebrate model, we generated dbh mutant zebrafish. In contrast to mice, these animals exhibit dramatically increased sleep. Surprisingly, despite an increase in sleep, dbh mutant zebrafish have a reduced arousal threshold. These phenotypes are also observed in zebrafish treated with small molecules that inhibit NE signaling, suggesting that they are caused by the lack of NE. Using genetic overexpression of hypocretin (Hcrt) and optogenetic activation of hcrt-expressing neurons, we also find that NE is important for Hcrt-induced arousal. These results establish a role for endogenous NE in promoting arousal and indicate that NE is a critical downstream effector of Hcrt neurons.

https://doi.org/10.7554/eLife.07000.001

eLife digest

Although the neural circuits that regulate sleep and wakefulness have yet to be fully identified, the importance of at least two brain regions is well established. These are the hypothalamus, a structure deep within the brain that controls a number of basic activities including hunger, thirst and sleep; and the brainstem, which connects the brain with the spinal cord.

Specific neurons within the hypothalamus and brainstem regulate the sleep–wake cycle by signaling to one another using chemicals called neurotransmitters and neuropeptides. Throughout the day, some hypothalamic neurons release a neuropeptide called hypocretin, which helps maintain wakefulness. Hypocretin acts on neurons within the brainstem and causes them to release other neurotransmitters that promote wakefulness. However, the identity of these molecules is unclear.

One candidate is norepinephrine. Drugs that enhance the effects of norepinephrine increase wakefulness, whereas those that block norepinephrine signaling promote sleep. Despite this, mice that have been genetically modified to lack the enzyme that produces norepinephrine exhibit relatively normal sleep. This may be because in mammals, norepinephrine also has important roles outside the brain, thus complicating the effects of this genetic modification on behavior. Alternatively, while zebrafish that lack norepinephrine are healthy, mice containing this modification die early in development. Treating these mice with a specific drug allows them to survive, but might affect their behavior.

To clarify the role of norepinephrine and its interaction with hypocretin, Singh, Oikonomou and Prober created a new animal model by genetically modifying zebrafish. In contrast to mice, zebrafish that were unable to make norepinephrine slept more than normal fish, although they were also lighter sleepers and were more prone to being startled. A genetic modification that increases hypocretin signaling induces insomnia; Singh, Oikonomou and Prober found that this occurs only in animals with normal levels of norepinephrine. Thus, these experiments indicate that hypocretin does indeed promote wakefulness though norepinephrine.

The work of Singh, Oikonomou and Prober has clarified the role of norepinephrine in regulating the sleep–wake cycle. These findings could help in the development of drugs that target the neurons that make hypocretin, which may improve treatments for sleep disorders.

https://doi.org/10.7554/eLife.07000.002

Introduction

Sleep remains among the most persistent and perplexing mysteries in modern biology. Several studies have shown that neuronal centers that regulate sleep and wakefulness lie predominantly in the hypothalamus and brainstem (Pace-Schott and Hobson, 2002; Saper et al., 2005), and many of the neurotransmitters and neuropeptides employed by these centers are known. However, it remains unclear how these centers interact with each other, and what specific functions are fulfilled by the neurotransmitters and neuropeptides they employ. Norepinephrine (NE) is one of the most abundant neurotransmitters in the central and peripheral nervous systems, and has been implicated in many aspects of physiology and behavior, including cognition, attention, reward, locomotion and arousal (Berridge and Waterhouse, 2003; Weinshenker and Schroeder, 2007; Sara, 2009). Small molecule activators of NE signaling have been shown to increase wakefulness, whereas inhibitors promote sleep (Berridge et al., 2012). These results suggest that NE plays a significant role in promoting arousal. However, the role of endogenous NE in regulating the sleep/wake cycles of vertebrates remains unclear, with contradicting reports concerning the sleep phenotype of mice that do not synthesize NE due to mutation of dopamine beta hydroxylase (dbh) (Hunsley and Palmiter, 2003; Ouyang et al., 2004).

The locus coeruleus (LC) in the brainstem is a major arousal promoting center and a major source of NE in the brain (reviewed in Berridge and Waterhouse, 2003). Optogenetic studies in mice have shown that activation of the LC promotes sleep-to-wake transitions, while inhibition of the LC reduces time spent awake (Carter et al., 2010, 2012). These studies also showed that activation of the LC plays an important role in mediating the arousing effects of hypocretin (hcrt)-expressing neurons (Carter et al., 2010, 2012), which constitute an important arousal center in the hypothalamus (Sutcliffe and de Lecea, 2002). These observations suggest that NE synthesized in the LC could be involved in mediating Hcrt-induced arousal. However, in addition to NE, the LC also produces other neurotransmitters and neuropeptides that affect sleep, including dopamine (Dzirasa et al., 2006), neuropeptide Y (Dyzma et al., 2010), neurotensin (Erwin and Radcliffe, 1993) and vasopressin (Born et al., 1992). Manipulations of the LC likely affect the synaptic levels of these other neurotransmitters and neuropeptides. Therefore, it is unclear whether NE is required to mediate the arousing effects of LC neurons and Hcrt signaling, or if this is accomplished by another factor in LC neurons.

To address the role of NE in regulating vertebrate sleep/wake states, we generated dbh mutant zebrafish that do not produce NE. Contrary to dbh null mice (Thomas et al., 1995), zebrafish dbh mutants develop normally and are viable. Importantly, they also exhibit a dramatic increase in sleep. Interestingly, despite increased sleep, these animals display a reduced arousal threshold. Using this mutant, we show that NE is important for arousal that is induced by either genetic overexpression of the Hcrt neuropeptide or optogenetic activation of Hcrt neurons. These results clarify the role of NE in regulating vertebrate sleep and establish a role for NE in mediating Hcrt-induced wakefulness.

Results

Pharmacological inhibition of NE signaling increases sleep

Previous pharmacological studies in zebrafish (Rihel et al., 2010) suggested that the noradrenergic system is an important regulator of sleep and wakefulness in zebrafish, similar to mammals (Berridge et al., 2012). Therefore, we reasoned that the zebrafish model system could provide a new platform for exploring the role of endogenous NE in sleep. Three classes of receptors mediate NE signaling: the activating alpha1-and beta-adrenergic receptors and the inhibitory alpha2 adrenergic receptors. For each class there exist at least 5 paralogs in the zebrafish genome, making pharmacological manipulations more practical than genetic manipulations. We first tested the effects of prazosin, a well-established alpha1-adrenergic receptor inhibitor, on zebrafish behavior. We found that, compared to larvae exposed to dimethyl sulfoxide (DMSO) vehicle alone, larvae exposed to 100 µM prazosin showed lower overall activity (Figure 1A,D) and activity when awake (Figure 1B,E) during both day and night, as well as an increase in sleep during both day (+140%) and night (+60%) (Figure 1C,F; Figure 1—figure supplement 1). This increase in sleep was primarily due to an increase in the number of sleep bouts (+110% during the day and +70% during the night, Figure 1G), as well as a smaller increase in sleep bout duration (+20% during the day) (Figure 1H). We also observed a 23% reduction in sleep latency at night in prazosin-treated animals (Figure 1I).

Figure 1 with 3 supplements see all
Download asset Open asset
Prazosin treated larvae are less active and sleep more than vehicle treated controls.

Representative activity (A), waking activity (amount of locomotor activity while awake) (B) and sleep (C) traces of vehicle (blue) and prazosin (red) treated zebrafish larvae. Bar graphs of activity (D), waking activity (E), sleep (F), sleep bout number (G), sleep bout length (H) and sleep latency (I) from three combined experiments (n > 180 for each condition). Bars represent mean ± s.e.m. *, p < 0.05 and ***, p < 0.0001 by one-way ANOVA.

https://doi.org/10.7554/eLife.07000.003

We further investigated whether treatment with the alpha2-adrenergic receptor agonist clonindine or the beta1-adrenergic receptor antagonist bopindolol affects the sleep of larval zebrafish. We found that the main effect of clonidine treatment was a reduction in day activity (−48%) and increase in day sleep (+90%), with no effect in night activity or sleep (Figure 1—figure supplement 2), suggesting a day-specific role for alpha2 receptors in sleep regulation. Bopindolol treatment resulted in reduction of night activity (−40%) and increase in both day (+82%) and night (+60%) sleep (Figure 1—figure supplement 3).

dbh mutant larvae exhibit increased sleep

Encouraged by our pharmacological studies, we decided to investigate the role of endogenous NE in sleep regulation using genetics. To this end we used the zinc-finger nuclease approach (Foley et al., 2009), a well established technique in zebrafish that induces targeted mutations with few off-target lesions (Doyon et al., 2008; Meng et al., 2008; Gupta et al., 2011), to generate zebrafish containing a mutation in the single zebrafish dopamine beta-hydroxylase (dbh) gene (Chen et al., 2013a), which encodes the enzyme that converts dopamine to NE. The dbh mutant allele that we generated contains a four nucleotide insertion in the third exon, which gives rise to a premature stop codon, resulting in a predicted 178 amino acid peptide lacking the DBH active site, instead of the full length 614 amino acid protein (Figure 2—figure supplement 1A).

Although the murine dbh knockout (Thomas et al., 1995) displays no overt developmental defects, only 10% of dbh−/− pups produced by dbh+/− mothers survive embryonic development and no dbh−/− pups are born to dbh−/− mothers. In contrast to the mouse knockout, female dbh−/− zebrafish produced a normal number of dbh−/− larvae when mated to dbh+/− males (out of 287 larvae genotyped from 3 independent crosses, 49% were dbh+/− and 51% were dbh−/−). We verified that dbh−/− larvae completely lack NE using an ELISA assay (Figure 2—figure supplement 1B). Using in situ hybridization (ISH) we also found that the level of dbh mRNA in dbh−/− larvae is much lower than in their dbh+/− siblings, presumably due to nonsense mediated decay of the mutant transcript (Isken and Maquat, 2007) (Figure 2—figure supplement 1C). While only 40% of dbh mutant mice that survive embryogenesis reach adulthood (Thomas et al., 1995), dbh−/− zebrafish embryos developed to adulthood normally (24/96 (25%) of embryos produced by a male dbh+/− crossed to female dbh+/−, and raised to adulthood, were identified as dbh−/−).

We used the dbh mutant to determine whether genetic ablation of NE affects the sleep/wake patterns of zebrafish larvae. We observed that dbh mutants display lower overall activity (Figure 2A,D) and activity when awake (Figure 2B,E) during both day and night. Importantly, we found that dbh−/− larvae sleep much more during both day (+185%) and night (+57%) than sibling controls (Figure 2C,F). During the day, the increase in sleep was due solely to more frequent sleep bouts (+220%), while during the night both longer (+17%) and more frequent (+25%) sleep bouts occurred (Figure 2G,H). Furthermore, sleep latency at night in the mutants was reduced by 40% (Figure 2I). It is interesting to note that, as expected, treatment of dbh mutants with 100 μM prazosin did not affect sleep/wake behavior compared to DMSO controls (Figure 2—figure supplement 2), suggesting that prazosin-induced behavioral effects are specific to NE signaling.

Figure 2 with 2 supplements see all
Download asset Open asset
dbh mutant larvae are less active and sleep more than sibling controls.

Representative activity (A), waking activity (B) and sleep (C) traces of dbh+/+ (blue) dbh+/− (cyan) and dbh−/− (red) zebrafish larvae. Bar graphs show mean ± s.e.m. activity (D), waking activity (E), sleep (F), sleep bout number (G), sleep bout length (H) and sleep latency (I) from seven combined experiments (n > 250 for each genotype). n indicates number of larvae. ***, p < 0.0001 and ns, not significant by one-way ANOVA.

https://doi.org/10.7554/eLife.07000.007

dbh mutant larvae exhibit lower arousal threshold

Since dbh mutants exhibit increased sleep, we decided to investigate whether their arousal threshold is also altered. To this end we delivered mechano-acoustic tapping stimuli of variable intensities to larvae while monitoring their behavior using a videotracking system. We delivered a stimulus once a minute during the night, and determined the fraction of larvae that responded to each stimulus. This dataset allowed us to construct dose–response curves (Figure 3A) and calculate the tapping intensity at which 50% of larvae responded to the stimulus (effective tap power 50, ETP50). Surprisingly, the ETP50 for dbh−/− larvae was 2.1 compared to 3.1 for their dbh+/+ siblings (32% decrease) (p < 0.0001 by extra sum-of-squares F test), suggesting that although the dbh mutants sleep more, they have a reduced arousal threshold. In addition to a lower ETP50, dbh−/− larvae also exhibited an increased maximal response fraction, from 0.43 for dbh−/− compared to 0.34 for dbh+/+ (p < 0.0001 by extra sum-of-squares F test). Interestingly, treatment with the alpha1-adrenergic antagonist prazosin or the alpha2-adrenergic agonist clonidine did not affect the arousal threshold of zebrafish larvae (data not shown). However, larvae treated with the alpha2-adrenergic antagonist bopindolol showed a 54% decrease in their ETP50 from 5.7 to 2.6 (Figure 3B, p < 0.0001 by extra sum-of-squares F test). The maximal response fraction was increased from 0.42 to 0.53 but this change did not achieve statistical significance (p = 0.08).

Figure 3
Download asset Open asset
dbh mutants and bopindolol-treated WT larave exhibit lower arousal threshold.

Stimulus-response curves generated by a tapping assay for dbh−/− and sibling control larvae (A), and bopindolol and DMSO treated WT larvae (B). Thirty trials were performed at each stimulus intensity, with a 1 min inter-trial interval. Each data point indicates mean ± s.e.m. Stimulus-response curves were constructed using the non-linear variable slope module in Prism and fitted using ordinary least squares. Dashed lines mark the ETP50 values for different genotypes and drug treatments. dbh−/− have an ETP50 value of 2.1 vs 3.1 for sibling controls (32% decrease, p < 0.0001 by extra sum-of-squares F test) (A), and bopindolol treated animals have an ETP50 value of 2.6 vs 5.7 for sibling controls (54% decrease, p < 0.0001 by extra sum-of-squares F test) (B). n indicates number of larvae.

https://doi.org/10.7554/eLife.07000.010

Hypocretin (hcrt) overexpression-induced wakefulness requires NE

The Hcrt neuropeptide has been shown to promote wakefulness and inhibit sleep in zebrafish larvae (Prober et al., 2006) and mammals (reviewed in Alexandre et al., 2013; Sakurai, 2013), and stimulation of Hcrt neurons has been shown to promote sleep to wake transitions in mice (Adamantidis et al., 2007). Hcrt has been proposed to promote wakefulness in part by stimulating the noradrenergic LC based on several lines of evidence. First, the LC is densely innervated by Hcrt neurons in both zebrafish (Prober et al., 2006) (Figure 4—figure supplement 1A,B) and mammals (Peyron et al., 1998; Chemelli et al., 1999; Date et al., 1999; Horvath et al., 1999) and LC neurons express the Hcrt receptor (Horvath et al., 1999; Bourgin et al., 2000; Prober et al., 2006). It is worth noting, however, that the medulla oblongata is another source of NE in the brain, and it also receives Hcrt projections in zebrafish (Figure 4—figure supplement 1C) and mammals (Ciriello et al., 2003; Zhang et al., 2004). Second, application of Hcrt peptide depolarizes LC neurons in brain slices (Hagan et al., 1999) and in vivo (Bourgin et al., 2000). Third, acute inhibition of LC neurons using halorhodopsin inhibits the arousing effects of stimulating Hcrt neurons (Carter et al., 2012). However, despite the evidence that the LC mediates Hcrt-induced arousal, it is unknown whether this process requires NE.

The mammalian genome contains two hcrt receptor (hcrtr) paralogs, both of which are required for the increase in locomotor activity and decrease in sleep observed after injection of Hcrt peptide (reviewed in Alexandre et al., 2013; Sakurai, 2013). To determine whether the single zebrafish hcrtr ortholog is required for the Hcrt overexpression phenotype in zebrafish larvae, we mated Tg(hsp:Hcrt) zebrafish to a previously described hcrtr mutant (Yokogawa et al., 2007). We subjected the larval progeny to heat shock (HS) during the sixth day post fertilization (dpf) to induce Hcrt overexpression (Prober et al., 2006). We then compared the amount of sleep on night 6 (post-HS) to night 5 (pre-HS). We previously showed that Hcrt protein levels remain elevated for over 48 hr after HS, with no detectable decrease during the first 24 hr after HS (Prober et al., 2006), so overexpressed Hcrt protein should remain at high levels throughout the night following HS. hcrtr+/− and hcrtr−/− larvae reacted similarly to the HS, with no significant difference in the amount of sleep between the two genotypes (Figure 4—figure supplement 2A,B). Hcrt overexpression decreased the sleep of Tg(hsp:Hcrt);hcrtr+/− larvae by 50% (Figure 4—figure supplement 2C,D), as previously described for Tg(hsp:Hcrt);hcrtr+/+ larvae (Prober et al., 2006). However, no decrease in sleep was observed in Tg(hsp:Hcrt);hcrtr−/− larvae following HS (Figure 4—figure supplement 2C,D). These results indicate that the decrease in sleep following overexpression of Hcrt requires a functional hcrtr.

To test the hypothesis that NE is required for Hcrt-induced wakefulness, we mated Tg(hsp:Hcrt)+/−;dbh+/− fish to dbh−/− fish and heat-shocked the larval progeny during day 6. We first asked whether the presence or absence of NE affects the response of larvae to HS. Larvae lacking the hsp:Hcrt transgene were similarly affected by the HS independently of whether they produced NE or not (no significant difference observed between dbh+/− and dbh−/− larvae, Figure 4A,B). We therefore conclude that lack of NE does not affect the response of larvae to HS. We next asked whether NE is required for Hcrt overexpression-induced arousal (Figure 4C,D). As expected, the amount of sleep exhibited by Tg(hsp:Hcrt) larvae was reduced following Hcrt overexpression (Figure 4D). Specifically, the sleep of Tg(hsp:Hcrt)+/−;dbh+/− larvae was reduced to 40% of the pre-HS value (Figure 4D). However, the sleep of Tg(hsp:Hcrt)+/−;dbh−/− larvae was reduced to 75% of the pre-HS value (Figure 4D). Thus, the majority of Hcrt-induced sleep loss is blocked in the absence of NE. Importantly, treatment of Tg(hsp:Hcrt)+/− animals with prazosin similarly inhibits Hcrt overexpression-induced arousal (Figure 4—figure supplement 3) suggesting that the dbh mutant phenotype is indeed due to the blocking of noradrenergic signaling. We also confirmed that the suppressed effect of Hcrt overexpression on sleep in dbh and hcrtr mutants is not due to an effect of the mutations on the efficacy of the HS overexpression system (Figure 4—figure supplement 4). These results indicate that NE plays an important role in Hcrt-mediated arousal, but suggest that Hcrt also inhibits sleep via NE-independent mechanisms.

Figure 4 with 4 supplements see all
Download asset Open asset
Reduced sleep at night due to Hcrt overexpression is suppressed in dbh mutants.

(A, C) Sleep traces from a single representative experiment; yellow region indicates time of heat shock (HS) during day 6. (B, D) Bar graphs show mean ± s.e.m. percentage change in sleep during night 6 compared to night 5 from four combined experiments. (B) In the absence of the hsp:Hcrt transgene, HS during day 6 has no significant effect on dbh−/− larvae compared to dbh+/− larvae. (D) The reduced sleep induced by Hcrt overexpression is significantly diminished in dbh−/− larvae compared to dbh+/− sibling controls. n indicates number of larvae. ***, p < 0.0001 and ns, not significant by one-way ANOVA.

https://doi.org/10.7554/eLife.07000.011

Activation of hcrt neurons using ChR2 increases locomotor activity

As an alternative approach to study the effects of activated Hcrt signaling on larval zebrafish behavior, we generated transgenic zebrafish in which the hcrt promoter (Faraco et al., 2006) drives expression of channelrhodopsin-2 fused to EYFP (hcrt:ChR2-EYFP). Using immunofluorescence, we verified that ChR2-EYFP is exclusively expressed in Hcrt neurons, and that all Hcrt neurons express ChR2-EYFP (Figure 5—figure supplement 1A). To test whether the hcrt:ChR2-EYFP transgene can activate Hcrt neurons, we exposed larvae to blue light for 30 min, and then performed double fluorescent ISH using probes specific for hcrt and c-fos. We observed that 40% of Hcrt neurons in Tg(hcrt:ChR2-EYFP) larvae expressed c-fos, compared to only 5% of Hcrt neurons in control Tg(hcrt:EGFP) larvae (Figure 5A,B). This result confirms that the light paradigm employed activates Hcrt neurons.

Figure 5 with 1 supplement see all
Download asset Open asset
Optogenetic activation of Hcrt neurons increases locomotor activity.

(A) Representative images of Hcrt neurons co-labeled with EYFP or EGFP (green) and c-fos (red). Scale bar = 10 μm. (B) Mean ± s.e.m. percentage of EYFP- or EGFP-expressing neurons that also express c-fos in Tg(hcrt:EGFP) and Tg(hcrt:ChR2-EYFP) larvae. (C) Representative locomotor activity trace during red light exposure. (D) Average locomotor activity relative to WT siblings during red light exposure. Data is pooled from 3 experiments and is represented as mean ± s.e.m. (E) Representative locomotor activity trace during blue light exposure. (F) Average locomotor activity relative to WT siblings during blue light exposure. Data is pooled from 4 experiments and is represented as mean ± s.e.m. Red and blue boxes in (C) and (E) indicate periods of red and blue light illumination. ‘A’ is the maximum activity reached for larvae of a particular genotype and ‘TA’ is the time taken to reach maximum activity A. n indicates number of larvae. ***, p < 0.0001 by one-way ANOVA.

https://doi.org/10.7554/eLife.07000.016

To test the behavioral effect of activating Hcrt neurons using ChR2, we developed a large-scale and non-invasive optogenetic behavioral assay. We modified the locomotor activity assay by adding an array of blue and red LEDs that uniformly illuminates the 96-well plate, thus allowing simultaneous light stimulation of 96 freely behaving larvae. Larvae at 5 dpf were transferred to a 96-well plate and kept in the dark for 8 hr in the behavioral chamber, after which they were exposed to either red or blue light for 30 min. The behavior of Tg(hcrt:ChR2-EYFP) larvae was compared to their non-transgenic siblings throughout the night with an inter-trial interval of 3 hr. A typical response to blue or red light included a burst of activity at light onset lasting approximately 30 s, followed by a return to near baseline activity levels, a gradual increase in activity that reached a plateau for the remainder of the illumination phase, and a burst of activity when the lights were turned off. The bursts of activity observed at light onset and offset were similar for transgenic and non-transgenic larvae and were excluded from behavioral analysis. Tg(hcrt:ChR2-EYFP) larvae and their non-transgenic siblings exhibited similar levels of locomotor activity when illuminated with red light (Figure 5C,D), a treatment that does not activate ChR2. In contrast, when illuminated with blue light the total locomotor activity of Tg(hcrt:ChR2-EYFP) larvae increased by 46% compared to non-transgenic siblings (Figure 5E,F). Activation of Hcrt neurons by ChR2 also altered the dynamics of locomotor activity. Specifically Tg(hcrt:ChR2-EYFP) larvae displayed a 25% increase in the maximum activity level reached during stimulation (Figure 5—figure supplement 1B) and reached this maximum activity level 20% faster (Figure 5—figure supplement 1C) than sibling controls.

We next asked whether the increase in locomotor activity observed upon activation of zebrafish Hcrt neurons using ChR2 requires the hcrtr. We first confirmed that hcrtr−/− larvae in the absence of the hcrt:ChR2-EYFP transgene respond to blue light in a manner similar to their hcrtr+/− and hcrtr+/+ siblings. Indeed, we observed no significant difference in the locomotor activity of larvae of the three genotypes during exposure to blue light (Figure 6A,B). However, Tg(hcrt:ChR2-EYFP);hcrtr−/− larvae were 25% less active than their Tg(hcrt:ChR2-EYFP);hcrtr+/− and Tg(hcrt:ChR2-EYFP);hcrtr+/+ siblings in response to blue light. This result indicates that a functional hcrtr is important for Hcrt neuron-induced arousal (Figure 6C,D).

Figure 6 with 1 supplement see all
Download asset Open asset
The hcrtr is required for Hcrt neuron-induced increased locomotor activity.

(A, C) Representative locomotor activity traces for hcrtr−/− and sibling controls without (A) and with (C) the hcrt:ChR2-EYFP transgene during blue light exposure. (B, D) Average locomotor activity relative to sibling controls. Data is pooled from 3 experiments in both cases. Data is represented as mean ± s.e.m. and is plotted as percentage of hcrtr+/+ (B) or hcrt:ChR2-EYFP; hcrtr+/+ (D). n indicates number of larvae. ***, p < 0.0001 and ns, not significant by one-way ANOVA followed by Tukey's test to correct for multiple comparisons.

https://doi.org/10.7554/eLife.07000.018

Mammalian and zebrafish Hcrt neurons coexpress other neurotransmitters and neuropeptides, such as glutamate and dynorphin (Chou et al., 2001; Rosin et al., 2003; Appelbaum et al., 2009; Liu et al., 2015), which could play a role in locomotor activity that is induced by stimulation of Hcrt neurons. Determining whether this is the case requires directly comparing locomotor activity in hcrtr−/− larvae with and without the hcrt:ChR2-EYFP transgene. Since these larvae were previously tested in separate experiments, we repeated the experiment but included all six genotypes in the same behavioral plates. As expected, blue light stimulation significantly increased locomotor activity for Tg(hcrt:ChR2-EYFP);hcrtr+/+ compared to hcrtr+/+ larvae, and for Tg(hcrt:ChR2-EYFP);hcrtr+/− compared to hcrtr+/− larvae (Figure 6—figure supplement 1). Tg(hcrt:ChR2-EYFP);hcrtr−/− were also more active than hcrtr−/− larvae, although the difference was much smaller than for Tg(hcrt:ChR2-EYFP);hcrtr+/+ compared to hcrtr+/+ larvae. Furthermore, Tg(hcrt:ChR2-EYFP);hcrtr+/+ larvae were significantly more active than Tg(hcrt:ChR2-EYFP);hcrtr−/− larvae. These results suggest that most, but not all, of the effect of stimulating Hcrt neurons on locomotor activity is due to Hcrt signaling, similar to results obtained in mammals (Adamantidis et al., 2007).

Thus, similar to Hcrt overexpression (Prober et al., 2006), optogenetic activation of only ∼8 larval zebrafish Hcrt neurons (an average of 40% of the 20 Hcrt neurons are c-fos positive upon stimulation with ChR2; Figure 5B) increases locomotor activity, consistent with a role for Hcrt neurons in promoting arousal (Lee et al., 2005; Mileykovskiy et al., 2005; Adamantidis et al., 2007; Carter et al., 2012). This effect appears to be significantly stronger than the phenotype described in mice (Adamantidis et al., 2007; Carter et al., 2012), suggesting that zebrafish may be more sensitive to the arousing effect of Hcrt. These experiments also demonstrate for the first time a large-scale and non-invasive application of optogenetics to manipulate the activity of a small population of neurons deep in the brain of freely behaving animals. This approach may be generally useful for studies of neuronal circuit function in regulating vertebrate behaviors.

Optogenetic stimulation of hcrt neurons activates dbh-expressing LC neurons

Based on our observation that larval zebrafish Hcrt neurons innervate the LC (Figure 4—figure supplement 1) and previous studies in mammals and zebrafish (Peyron et al., 1998; Chemelli et al., 1999; Date et al., 1999; Horvath et al., 1999; Kaslin et al., 2004; Prober et al., 2006), we sought to explore the functional interaction between the two neuronal populations using a combination of optogenetics and calcium imaging. Using a transient injection approach (see ‘Materials and methods’), we generated Tg(hcrt:ChR2-EYFP) and Tg(hcrt:EGFP) larvae in which single LC neurons expressed the genetically encoded calcium indicator GCaMP6s. After paralyzing and mounting these larvae in low melt agarose, we illuminated with a 488 nm laser a region of the brain containing the Hcrt neuron soma with 10 short pulses (0.3 s each over 3.2 s total), then imaged GCaMP6s fluorescence in the LC for 30 s (Figure 7A). We reasoned that even though we did not stimulate Hcrt neurons and image the LC simultaneously, the short time interval between the final stimulation pulse and the initiation of imaging (<0.1 s), and the relatively slow kinetics of GCaMP6s fluorescence changes (Chen et al., 2013b), would allow us to detect Hcrt neuron-induced effects on LC neuron activity. Indeed, over multiple trials in several animals we observed a significant increase in GCaMP6s fluorescence in Tg(hcrt:ChR2-EYFP) larvae, but not in Tg(hcrt:EGFP) larvae (Figure 7B–E, Videos 1 and 2), indicating that stimulation of Hcrt neurons results in activation of the LC in zebrafish larvae.

Figure 7
Download asset Open asset
Optogenetic stimulation of Hcrt neurons activates LC neurons.

(A) Schematic representation of areas stimulated (Hcrt, yellow) and imaged (LC, green). a = anterior, p = posterior. (B, C) Representative images of a LC cell expressing GCaMP6s in a Tg(hcrt:EGFP) (B) or Tg(hcrt:ChR2-EYFP) (C) larva before (B, C) and immediately after (B′, C′) stimulation of Hcrt neuron region. (D) GCaMP6s fluorescence intensity for a representative LC neuron in a Tg(hcrt:EGFP) (top) and a Tg(hcrt:ChR2-EYFP) (bottom) larva. Single-trial (gray) and average (black) responses are shown. (E) Mean ± s.e.m. ∆F/F (%) values averaged for all trials. n indicates number of trials for 5 Tg(hcrt:EGFP) and 4 Tg(hcrt:ChR2-EYFP) larvae. ***, p < 0.001 by one-way ANOVA. See Videos 1 and 2 for examples of GCaMP6s imaging.

https://doi.org/10.7554/eLife.07000.020
Video 1
Download asset
Pulsed illumination of hcrt:EGFP neurons does not affect GCaMP6s fluorescence in LC neurons.

Two trials for a representative LC neuron are shown. Frames labeled ‘Stimulation’ indicate periods during which the soma of Hcrt neurons were illuminated by ten 0.3 s pulses of 488 nm light, during which time GCaMP6s was not imaged in the LC. See Figure 7 for quantification.

https://doi.org/10.7554/eLife.07000.021
Video 2
Download asset
Pulsed illumination of hcrt:ChR2-EYFP neurons increases GCaMP6s fluorescence in LC neurons.

Two trials for a representative LC neuron are shown. Frames labeled ‘Stimulation’ indicate periods during which the soma of Hcrt neurons were illuminated by ten 0.3 s pulses of 488 nm light, during which time GCaMP6s was not imaged in the LC. See Figure 7 for quantification.

https://doi.org/10.7554/eLife.07000.022

NE is important for locomotor activity induced by optogenetic activation of hcrt neurons

Optogenetic studies in rodents have shown that acute inhibition of LC neurons blocks the wake-promoting effects of acute activation of Hcrt neurons (Carter et al., 2012). However, the contribution of NE to this phenotype is unclear. To test the hypothesis that NE is required for the arousing effect of Hcrt neuron stimulation, we assayed the behavioral effects of optogenetically activated Hcrt neurons in dbh−/− larvae (Figure 8). As we previously observed (Figure 2D,E), dbh−/− larvae were significantly less active during the 30 min of baseline recording than sibling controls (dbh+/+ 31.0 ± 4.0, dbh+/− 39.7 ± 4.1 and dbh−/− 15.7 ± 2.6 s of activity, p < 0.05 by one-way ANOVA). dbh−/− larvae were also 25% less responsive to blue light than both dbh+/+ and dbh+/− larvae (Figure 8A,B). However, when Hcrt neurons were activated optogenetically the requirement for NE became more pronounced, as the ChR2-induced increase in locomotor activity was reduced by 76% in Tg(hcrt:ChR2-EYFP);dbh−/− larvae compared to both Tg(hcrt:ChR2-EYFP);dbh+/+ and Tg(hcrt:ChR2-EYFP);dbh+/− siblings (Figure 8C,D). Thus, while it is possible that supranormal optogenetic activation of Hcrt neurons could make NE more important for Hcrt-induced locomotor activity than it is under normal conditions, these results suggest that NE is an important effector of Hcrt-neuron induced arousal.

Figure 8
Download asset Open asset
dbh is required for Hcrt neuron-induced increased locomotor activity.

(A, C) Representative locomotor activity traces for dbh−/− and sibling control larvae without (A) and with (C) the hcrt:ChR2-EYFP transgene during blue light exposure. (B, D) Average locomotor activity relative to sibling controls. Data is pooled from 2 (B) or 3 (D) experiments. Data is represented as mean ± s.e.m. and is plotted as percentage of dbh+/+ (B) or hcrt:ChR2-EYFP; dbh+/+ (D). n indicates number of larvae. *, p < 0.05 and ***, p < 0.0001 by one-way ANOVA followed by Tukey's test to correct for multiple comparisons.

https://doi.org/10.7554/eLife.07000.023

Discussion

The first catecholamine to be identified as a neurotransmitter by Ulf von Euler in 1946, NE has been implicated in many aspects of physiology and behavior (Berridge and Waterhouse, 2003; Weinshenker and Schroeder, 2007; Sara, 2009). Several lines of evidence indicate that exogenous NE is a potent arousal-promoting agent (reviewed in Berridge et al., 2012). In Drosophila, lack of endogenous octopamine, which is considered the invertebrate equivalent of NE, results in increased sleep (Crocker and Sehgal, 2008). However, the role of endogenous NE in regulating vertebrate sleep remains unclear.

The murine dbh knockout (Thomas et al., 1995) displays no overt developmental defects. However, only 10% of dbh−/− pups produced by dbh+/− mothers survive embryonic development and no dbh−/− pups are born to dbh−/− mothers; all such embryos die by embryonic day 13.5 (Thomas et al., 1995). Of the dbh−/− pups that survive embryogenesis, only 40% reach adulthood. Although the basis of the embryonic lethality is unclear, it was hypothesized to be due to abnormal heart development or function, as the hearts of mutant embryos display greater heterogeneity in cell size and orientation (Thomas et al., 1995). Supplementation of drinking water during gestation with dihydroxyphenylserine (DOPS), which is converted to NE by L-aromatic-amino-acid decarboxylase (AADC), rescues the embryonic lethal phenotype. Following birth, DOPS supplementation is not required for continued survival of dbh−/− pups. Surprisingly, dbh−/− mice that reach adulthood were initially reported as having normal sleep/wake cycles (Hunsley and Palmiter, 2003), although a later study reported a 20% increase in sleep (Ouyang et al., 2004). These contradictory results could arise from differences in methodology, a relatively subtle and thus poorly reproducible sleep phenotype, or the complication that mice lacking dbh also exhibit higher levels of dopamine, the substrate of DBH and a major neurotransmitter in the brain.

In this study we sought to clarify the role of endogenous NE in regulating vertebrate sleep using pharmacology and genetics in zebrafish. Sleep can be distinguished from inactivity using electrophysiology or three behavioral criteria (Campbell and Tobler, 1984; Borbely and Tobler, 1996; Allada and Siegel, 2008). First, sleep primarily occurs during specific periods of the circadian cycle. Second, animals exhibit an increased arousal threshold during sleep, although they can still be aroused by strong stimuli, thus distinguishing sleep from paralysis or coma. Third, sleep is controlled by a homeostatic system, which can be demonstrated as an increased need for sleep following sleep deprivation. Based on these criteria, it has been shown that rest in a variety of organisms, including zebrafish (Zhdanova et al., 2001; Prober et al., 2006; Yokogawa et al., 2007), meets the behavioral definition of sleep. Several groups have demonstrated behavioral, anatomical, genetic and pharmacological conservation of sleep between zebrafish and mammals, establishing zebrafish as a simple vertebrate model for sleep research (Zhdanova et al., 2001; Kaslin et al., 2004; Faraco et al., 2006; Prober et al., 2006; Renier et al., 2007; Yokogawa et al., 2007; Rihel et al., 2010; Gandhi et al., 2015).

To study the function of NE in regulating zebrafish sleep, we generated a predicted null mutation in the single zebrafish dbh ortholog (Figure 2—figure supplement 1). Unlike mice, dbh−/− zebrafish larvae develop normally yet show reduced activity and strikingly increased sleep (+185% during the day and +57% during the night) compared to sibling controls (Figure 2). Importantly, these phenotypes were also observed in larvae treated with the alpha-adrenergic inhibitor prazosin (Figure 1), which blocks NE signaling without affecting dopamine levels. This observation suggests that the zebrafish dbh−/− phenotypes are due to lack of NE and not altered dopamine levels.

It is important to note that our pharmacological manipulations (blocking of the activating alpha1-adrenergic receptors with the antagonist prazosin; activation of the inhibitory alpha2-adrenergic receptors with the agonist clonidine; blocking of the activating alpha2-adrenergic receptors with the antagonist bopindolol) did not fully recapitulate the activity and sleep phenotypes observed in the dbh mutant. This is not surprising considering the inherent limitations of global exposure to a drug and the fact that each receptor type has at least five paralogs in zebrafish that may have different sensitivities to these drugs. Among these drugs, prazosin most faithfully phenocopied the dbh sleep/wake phenotype (reduced day and night activity and increased day and night sleep) with differences observed in sleep bout number. Clonidine reduced activity and increased sleep during the day, but had almost no effect at night. Bopindolol increased sleep during the day and night, but only inhibited activity at night. These observations suggest that alpha1-adrenergic receptors could be the main facilitators of noradrenergic modulation of larval zebrafish sleep.

Why do dbh mutant mice fail to exhibit the robust sleep phenotypes observed in NE deficient zebrafish? One possible explanation is that the chronic loss of NE in dbh mutant mice may induce compensatory mechanisms during development that do not occur in response to chronic loss of NE in zebrafish. Another possibility is that DOPS treatment during gestation affects developmental processes that ultimately affect behavior. An intriguing third potential explanation involves the role of NE in the mammalian sympathetic nervous system in promoting brown adipose tissue (BAT) thermogenesis (Cannon and Nedergaard, 2004). BAT thermogenesis has been shown to promote slow wave sleep (Dewasmes et al., 2003) and to be required for sleep rebound after sleep deprivation (Szentirmai and Kapas, 2014). Therefore, genetic ablation of dbh could induce two competing effects. In the periphery, lack of NE reduces BAT thermogenesis and thus inhibits sleep. In the central nervous system, lack of NE interferes with the normal arousal function of the LC and thus inhibits wakefulness. The combination of these two opposing forces could result in a minor sleep increase in dbh−/− mice, and the magnitude of this phenotype might be particularly sensitive to experimental conditions. However, zebrafish larvae and flies do not regulate their body temperature and are thus subject only to the sleep promoting effects of NE ablation, resulting in a dramatic increase in sleep. It would be interesting to test whether mice in which dbh is deleted only centrally, and thus have normal BAT thermogenesis in the periphery, display a similarly dramatic sleep increase.

To further characterize the dbh phenotype, we used an automated arousal threshold assay using a mechano-acoustic stimulus. We were surprised to find that although dbh−/− larvae sleep more, they display a lower arousal threshold (i.e. they respond to stimuli of lower intensity), as well as a higher maximal response than sibling controls (Figure 3A). Genetic ablation of dbh is predicted to increase dopamine levels in neurons that normally express dbh, since this enzyme converts dopamine to NE. Indeed, dopamine levels are higher in dbh mutant mice compared to sibling controls (Thomas et al., 1995). However, pharmacological inhibition of adrenergic receptors should not interfere with the conversion of dopamine to NE. Interestingly, we were able to pharmacologically replicate the reduced arousal phenotype seen in dbh−/− animals by treatment with bopindolol, a beta-adrenergic inhibitor, but not with the alpha1-adrenergic inhibitor prazosin, or the alpha2-adrenergic agonist clonidine. The ability of bopindolol to recapitulate the reduction in arousal threshold seen in the dbh mutant suggests that this aspect of the mutant phenotype is a consequence of the silencing of beta-adrenergic receptor signaling. Furthermore, the inability of prazosin (which increases sleep during day and night) or clonidine (which increases sleep during the day) to recapitulate the phenotype suggests that the observed reduction in arousal threshold is not simply a consequence of lighter sleep due to ‘over-sleeping’ in the dbh mutant. These observations suggest that lack of beta-adrenergic receptor signaling potentiates responses to sensory stimuli, and are particularly interesting considering that NE reuptake inhibitors such as atomoxetine, which increase NE signaling, are used to treat patients suffering from Attention Deficit/Hyperactivity Disorder (ADHD) (Garnock-Jones and Keating, 2009). It is important to note that these pharmacological results do not preclude a role of excess dopamine release in the dbh mutant by the previously noradrenergic neurons of the LC and/or medulla oblongata in reducing the arousal threshold. This hypothesis is supported by zebrafish studies implicating dopamine in arousal modulation (Burgess and Granato, 2007; Mu et al., 2012) as well as work demonstrating that dopaminergic stimulation during anesthesia produces a robust arousal response (Taylor et al., 2013). Furthermore, dopamine agonists have been shown to increase locomotion in zebrafish larvae (Rihel et al., 2010; Irons et al., 2013) and dopamine promotes locomotor development in zebrafish larvae (Lambert et al., 2012).

The Hcrt neurons of the hypothalamus are a major arousal promoting center. Several lines of evidence suggest that Hcrt promotes arousal, at least in part, via the LC. First, Hcrt neurons send dense projections to the LC in rodents and zebrafish (Peyron et al., 1998; Chemelli et al., 1999; Date et al., 1999; Horvath et al., 1999; Kaslin et al., 2004; Prober et al., 2006) (Figure 4—figure supplement 1A,B). Second, the LC expresses the Hcrt receptor in rodents (Horvath et al., 1999; Bourgin et al., 2000) and zebrafish (Prober et al., 2006). Third, application of Hcrt peptide depolarizes LC neurons in brain slices (Hagan et al., 1999) and in vivo (Bourgin et al., 2000). Fourth, optogenetic activation of Hcrt neurons induces c-Fos expression in the LC of mice (Carter et al., 2012) and GCaMP6 activation in the LC of zebrafish larvae (Figure 7). Fifth, acute inhibition of LC neurons blocks the effect of acute Hcrt neuron activation on sleep to wake transitions (Carter et al., 2012). While these studies suggest that the LC plays an important role in mediating Hcrt-induced arousal, it was unknown whether NE, a neurotransmitter in the LC, is required for this process. This question is important because the LC produces other neurotransmitters and neuropeptides that have been shown to affect sleep, including dopamine (Dzirasa et al., 2006), neuropeptide Y (Dyzma et al., 2010), neurotensin (Erwin and Radcliffe, 1993) and vasopressin (Born et al., 1992).

To address this question, we used two independent strategies to drive Hcrt-induced arousal. First, we overexpressed Hcrt using a heat-shock inducible promoter, which was previously shown to decrease sleep in zebrafish larvae (Prober et al., 2006). We observed that in the absence of NE, sleep reduction was attenuated (Figure 4). Second, we developed a large-scale and non-invasive optogenetic assay and used it to activate Hcrt neurons in freely behaving larvae (Figure 5). Similar to Hcrt overexpression, activation of Hcrt neurons increased locomotor activity, consistent with the increased sleep-to-wake transitions previously described in mammals (Adamantidis et al., 2007). This observation provides evidence of a causal relationship between the activity of Hcrt neurons and locomotor activity in zebrafish, and together with data from the mouse (Adamantidis et al., 2007) supports an evolutionarily conserved role of Hcrt neurons in promoting arousal. We found that the arousing effects of Hcrt overexpression (Figure 4) and Hcrt neuron activation (Figure 8) were dramatically reduced in dbh mutant larvae, indicating that NE is an important downstream effector of Hcrt-mediated arousal.

Interestingly, lack of NE did not completely abolish arousal induced by Hcrt overexpression (Figure 4), suggesting that Hcrt also promotes arousal via NE-independent pathways. Whether these pathways employ other molecules produced by the LC or are LC-independent remains to be tested. Zebrafish Hcrt neurons also send projections to noradrenergic cells in the medulla oblongata, similar to mammals (Ciriello et al., 2003; Zhang et al., 2004), suggesting that these cells might also mediate Hcrt-induced arousal. Furthermore, in humans, Hcrt neurons are reciprocally connected to other important arousal centers such as the cholinergic basal forebrain, the histaminergic tuberomammillary nucleus, the dopaminergic ventral tegmental area and the serotonergic dorsal raphe (Alexandre et al., 2013). Many of these connections are also present in zebrafish, with Hcrt neurons projecting to dopaminergic, histaminergic and serotonergic populations (Panula et al., 2010). Although functional interactions between Hcrt neurons and these populations have yet to be explored in zebrafish, the anatomical and molecular similarities of zebrafish and mammalian brains suggest that at least a portion of Hcrt-induced arousal is likely to be mediated by these centers.

In summary, we have demonstrated that endogenous NE is required to maintain normal levels of wakefulness in a diurnal vertebrate. This study, together with previous reports in Drosophila (Crocker and Sehgal, 2008) and mice (Ouyang et al., 2004), support a phylogenetically conserved role for endogenous NE in promoting wakefulness. Furthermore, we showed that NE also plays an important role in mediating arousal induced by either overexpression of the Hcrt peptide or activation of Hcrt neurons. Finally, we established and characterized the zebrafish dbh mutant, a useful tool for studying other processes that are thought to involve NE, including the fight-or-flight response (Colwill and Creton, 2011), congestive heart failure (Thomas and Marks, 1978), cognitive disorders such as Alzheimer's (Chalermpalanupap et al., 2013) and Parkinson's diseases (Rommelfanger et al., 2007), and neuropsychiatric disorders including depression and ADHD (Chamberlain and Robbins, 2013).

Materials and methods

Ethics statement

Request a detailed protocol

All experiments followed standard protocols (Westerfield, 2000) in accordance with the California Institute of Technology Institutional Animal Care and Use Committee guidelines (animal protocol 1580).

Transgenic and mutant zebrafish

Tg(hcrt:ChR2(H134R)-EYFP

Request a detailed protocol

A 1 kilobase (kb) genomic fragment upstream of zebrafish hcrt, described previously (Faraco et al., 2006), was amplified using the primers 5′-ATAATAAATAAATCTGATGGGGTTTT-3′ and 5′-GAGTTTAGCTTCTGTCCCCTG-3′, and subcloned 5′ to a transgene encoding the H134R variant of channelrhodopsin-2 (ChR2) fused to EYFP (Nagel et al., 2005; Lin et al., 2009), in a plasmid containing Tol2 transposase recognition sequences. This plasmid was co-injected with Tol2 transposase mRNA to generate Tg(hcrt:ChR2-EYFP) stable transgenic lines. Screening for EYFP expression identified several stable lines, two of which were used for experiments. Both lines expressed EYFP specifically in Hcrt neurons. One line had a single insertion of the transgene and exhibited weak EYFP fluorescence. For the experiment described in Figure 5, animals heterozygous for the transgene were incrossed to compare sibling larvae exhibiting no EYFP (wild-type) and moderate EYFP (homozygous transgenic) fluorescence. Stimulation of Hcrt neurons using ChR2 had a much stronger effect on locomotor activity in homozygous transgenic animals compared to heterozygotes. We did not use this line in combination with hcrtr and dbh mutants in the same experiment because the number of larvae of each genotype from a mating was too low to obtain robust data. The second line contained multiple insertions of the transgene and outcrossing these fish produced larvae with EYFP fluorescence intensities ranging from weak to strong. We used this line for experiments that required outcrossing to hcrtr or dbh mutants in order to obtain larvae with strong ChR2 expression. Adults from this line were mated with hcrtr or dbh mutants, and larvae with strong EYFP fluorescence were raised to adulthood. These heterozygous mutants were then incrossed to generate larvae for behavioral experiments. All larvae expressed ChR2-EYFP with varying fluorescent intensities due to multiple insertions of the transgene. At the end of each behavioral experiment, EYFP fluorescence was visualized and only larvae with bright fluorescence were used for analysis. To determine the effect of blue light stimulation on hcrtr or dbh mutants without the ChR2-EYFP transgene, heterozygous mutant fish were incrossed to obtain homozygous mutant, heterozygous mutant and wild type sibling larvae.

For Hcrt overexpression experiments, fish heterozygous for the hsp:Hcrt transgene and for the hcrtr or dbh mutation were mated to fish that were homozygous for the hcrtr or dbh mutation. The behavior of larvae with or without the hsp:Hcrt transgene was then compared in heterozygous and homozygous mutants. This mating scheme was used to ensure that each experiment had enough larvae of each genotype to obtain robust data. The hcrtr mutant (Yokogawa et al., 2007), dbh mutant (Chen et al., 2013a), Tg(dbh:EGFP) transgenic line (Liu et al., 2015), Tg(hcrt:RFP) transgenic line (Liu et al., 2015) and Tg(hsp:Hcrt) transgenic line (Prober et al., 2006) have previously been described. Tg(hsp:Hcrt) fish were genotyped using the primers 5′-CGGGACCACCATGGACT-3′ and 5′-GGTTTGTCCAAACTCATCAATGT-3′, which generate a 470 bp band. dbh mutant fish were genotyped using the primers 5′-GAGCTCATGCAACGAAC-3′, 5′-GTAAAACTCAACTGTTTACCTAAAG-3′ and 5′-GTGCGTACATCTTTCGGG -3′, which generate 1 band for wild type (198 bp), two bands for homozygous mutant (113 bp and 202 bp) and three bands for heterozygous mutant (113 bp, 198 bp and 202 bp). hcrtr mutant fish were genotyped using the primers 5′-CCACCCGCTAAAATTCAAAAGCACTGCTAAC-3′ and 5′-CATCACAGACGGTGAACAGG-3′, which generate a 170 bp product that is cut by DdeI (New England Biolabs, Ipswich, MA, United States) in the mutant to produce 140 and 30 bp bands. We outcrossed the dbh mutant to the parental TLAB wild type strain three times to reduce the possibility of unlinked mutations, and we did not observe developmental defects that can be indicative of such mutations. During the course of routine genotyping by fin clipping, we found that adult dbh−/− fish often die following anesthesia with tricaine (E10521, Sigma-Aldrich, St. Louis, MO, United States) at a commonly used dose (0.16 mg/ml). A lower concentration of tricaine (0.08 mg/ml) allowed survival of dbh−/− fish. Furthermore, dbh−/− fish sometimes died during or shortly after mating, perhaps due to a heightened sensitivity to stress. dbh−/− larvae respond normally to sensory stimuli such as gentle poking.

Sleep/wake analysis

Request a detailed protocol

Sleep/wake analysis was performed as previously described (Prober et al., 2006). Larvae were raised on a 14/10 hr light/dark (LD) cycle at 28.5°C with lights on at 9 am and off at 11 pm. Dim white light was used to raise larvae for optogenetic experiments to prevent stimulation of ChR2 by ambient light. Individual larvae were placed into each well of a 96-well plate (7701-1651, Whatman, Pittsburgh, PA, United States) containing 650 μl of E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7.4). Locomotor activity was monitored using a videotracking system (Viewpoint Life Sciences, Lyon, France) with a Dinion one-third inch Monochrome camera (Dragonfly 2, Point Grey, Richmond, Canada) fitted with a variable-focus megapixel lens (M5018-MP, Computar, Cary, NC, United States) and infrared filter. The movement of each larva was recorded using the quantization mode. The 96-well plate and camera were housed inside a custom-modified Zebrabox (Viewpoint Life Sciences) that was continuously illuminated with infrared lights. The 96-well plate was housed in a chamber filled with recirculating water to maintain a constant temperature of 28.5°C. The parameters used for movement detection were: detection threshold, 15; burst, 29; freeze, 3; bin size, 60 s. Data were analyzed using custom Perl and Matlab (Mathworks, Natick, MA, United States) scripts (Source code 1), which conform to the open source definition.

For Hcrt overexpression experiments, videotracker analysis was initiated at 4 dpf. During the afternoon of 6 dpf, the 96-well plate was transferred to a 37°C water bath for 1 hr to induce Hcrt overexpression. For each larva, total sleep during night 6 was divided by the average total sleep on night 5 for all larvae of the same genotype and converted to a percentage to compare among different genotypes.

Pharmacology

Request a detailed protocol

Prazosin hydrochloride (P7791, Sigma–Aldrich), clonidine hydrochloride (C7897, Sigma–Aldrich) and bopindolol malonate (SC-200144, Santa Cruz Biotechnology, Dallas, TX, United States) were dissolved in dimethyl sulfoxide (DMSO, 4948-02, Macron Chemicals, Center Valley, PA, United States) and added to E3 medium for a final concentration of 0.1% DMSO and 100 μM prazosin, 5 μM clonidine or 20 μM bopindolol. At these concentrations, we observed robust behavioral phenotypes without apparent toxicity or abnormal responses to a gentle stimulus. Controls were exposed to 0.1% DMSO alone. For sleep/wake experiments drugs were added during the evening of the fourth day of development and recording was performed from the beginning of day 5 until the end of night 6. For arousal experiments, drugs were added in the afternoon of day 5, and experiments were performed during night 5 (12:30 am to 7:30 am).

Analysis of dbh expression and NE levels

Request a detailed protocol

dbh ISH was performed using standard protocols (Thisse and Thisse, 2008) and developed using nitro-blue tetrazolium and 5-bromo-4-chloro-3′-indolyphosphate (10760978103, Roche, Mannheim, Germany). A fragment of the dbh gene was used as a probe (Guo et al., 1999). NE levels were measured using an ELISA assay (17-NORHU-E01-RES, ALPCO, Salem, NH, United States) according to the manufacturer's instructions. Five larvae were analyzed per sample, with four samples analyzed in triplicate for each genotype.

Arousal threshold assay

Request a detailed protocol

The videotracking system was modified by adding an Arduino (http://www.arduino.cc/) based automated driver to control two solenoids (28P-I-12, Guardian Electric, Woodstock, IL, United States) that delivered a tap to a 96-well plate containing larvae. This setup allowed us to drive the solenoids with voltage ranging from 0 V to 20 V over a range of 4095 settings (from 0.01 to 40.95). In our experiments we used taps ranging from a power setting of 1–36.31. Taps of 14 different intensities were applied in a random order from 12:30 am to 7:30 am during the fifth night of development with an inter-trial-interval of 1 min. Previous studies showed that a 15 s interval between repetitive stimuli is sufficient to prevent behavioral habituation (Burgess and Granato, 2007; Woods et al., 2014). The background probability of movement was calculated by identifying for each genotype the fraction of larvae that moved 5 s prior to all stimuli delivered during an experiment (14 different tap powers x 30 trials per experiment = 420 data points per larva; average background movement). This value was subtracted from the average response fraction value for each tap event (corrected response = average response – average background movement). The response of larvae to the stimuli was monitored using the videotracking software and was analyzed using Matlab (Mathworks) and Excel (Microsoft, Redmond, WA, United States). Statistical analysis was performed using the Variable Slope log(dose) response curve fitting module of Prism (Graphpad, La Jolla, CA, United States).

Immunofluorescence

Request a detailed protocol

Samples were fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4°C and then washed with 0.25% Triton X-100/PBS (PBTx). Brains were manually dissected and blocked for at least 1 hr in 2% goat serum/2% DMSO/PBTx at room temperature or overnight at 4°C. Antibody incubations were performed in blocking solution overnight at 4°C. Primary antibodies were rabbit anti-orexin A (AB3704, 1:500; Millipore, Temecula, CA, United States), rabbit anti-RFP (632496, 1:100, Clontech, Mountain View, CA, United States) and chicken anti-GFP (GFP-1020, 1:400, AvesLabs, Tigard, OR, United States). Alexa Fluor secondary antibodies were used (1:500 for anti-orexin and anti-RFP and 1:600 for anti-GFP, Life Technologies, Carlsbad, CA, United States). Samples were mounted in 50% glycerol/PBS and imaged using a Zeiss LSM 780 confocal microscope (Zeiss, Oberkochen, Germany).

ISH

Request a detailed protocol

To exclude the possibility that the HS promoter response is suppressed in hcrtr and dbh mutants, we performed ISH to compare the level of overexpressed hcrt mRNA in hcrtr and dbh homozygous mutants to their heterozygous mutant siblings. Fish heterozygous for the hsp:Hcrt transgene and for the hcrtr or dbh mutation were mated to hcrtr or dbh homozygous mutants, respectively. Larvae from these crosses were heat shocked during the afternoon at 6 dpf to induce hcrt overexpression, and were fixed 30 min after HS in 4% PFA overnight at room temperature. ISH was performed using digoxygenin (DIG) labeled antisense riboprobes (Thisse and Thisse, 2008). Images were acquired using a Zeiss AxioImagerM1 microscope and samples were then genotyped by PCR.

Assay for activation of hcrt-expressing neurons by ChR2

Request a detailed protocol

Tg(hcrt:ChR2-EYFP) larvae were placed in a 96 well plate in the videotracking system as described above, left in the dark for 8 hr, and then exposed to blue light for 30 min starting at 1 am. Larvae were then fixed in 4% PFA overnight at 4°C. Double-fluorescent ISH was performed using DIG- and 2,4-dinitrophenol (DNP)-labeled riboprobes and the TSA Plus DNP System (NEL747A001 KT, PerkinElmer, Waltham, MA, United States). Probes specific for c-fos and eyfp were used to quantify the number of eyfp-expressing Hcrt neurons that expressed c-fos. Tg(hcrt:EGFP) larvae (Prober et al., 2006) were used as negative controls. Samples were mounted in 50% glycerol/PBS and imaged using a Zeiss 780 LSM confocal microscope.

Optogenetic behavioral assay and analysis

Request a detailed protocol

The videotracking system was modified to include a custom array containing three sets of red and blue LEDs (627 nm, MR-D0040-10S and 470 nm, MR-B0040-10S, respectively, Luxeon V-star, Brantford, Canada) mounted 15 cm above and 7 cm away from the center of the 96-well plate to ensure uniform illumination. The LEDs were controlled using a custom built driver and software written in BASIC stamp editor. A power meter (1098293, Laser-check, Santa Clara, CA, United States) was used before each experiment to verify uniform light intensity (∼400 µW at the surface of the 96-well plate) and similar red and blue light intensities were used. During the afternoon of the fifth day of development, single larvae were placed into each well of a 96-well plate as described above and placed in the videotracker in the dark for 8 hr. Larvae were then exposed to either red or blue light for 30 min, starting at 1 am. Three trials were performed during the night, with an inter-trial interval of 3 hr. Total activity for each larva was monitored for 30 min before and after light onset, with data collected in 10 s bins. Light onset caused a short burst of locomotor activity lasting for ∼30 s for all genotypes, so data obtained during the minute before and after light onset was excluded from analysis. A large burst of locomotor activity was also observed for all genotypes when the lights were turned off after the 30 min illumination period. This data was excluded from analysis and is not shown in the figures. The total amount of locomotor activity of each larva during the 30 min of light exposure, excluding the minute after light onset, was divided by the average baseline locomotor activity for all larvae of the same genotype. The baseline period was defined as 30 min before light onset, excluding the minute before light onset. Data from multiple experiments were pooled and converted to percentage of wild type larvae.

GCaMP6s imaging

Request a detailed protocol

A 1.1 kb genomic fragment upstream of the dbh gene was amplified using the primers 5′-ACTTGAACCAGCGACCTTCT-3′ and 5′-GGTTTGAAGGCCTTTCTAAGTTTTT-3′ (Liu et al., 2015) and cloned 5′ to a transgene encoding GCaMP6s (Chen et al., 2013b) in a plasmid containing Tol2 transposase recognition sequences. Either Tg(hcrt:ChR2-EYFP) or Tg(hcrt:EGFP) embryos were injected at the 1–2 cell stage with a solution containing 50 ng/µl plasmid, 0.04% phenol red and 50 ng/µl Tol2 transposase mRNA. This injection procedure resulted in GCaMP6s expression in no more than 1 LC neuron per animal. At 5 dpf, larvae were paralyzed by immersion in 1 mg/ml α-bungarotoxin (2133, Tocris, Bristol, UK) dissolved in E3, embedded in 1% low melting agarose (EC-202, National Diagnostics, Atlanta, GA, United States) and imaged using a 20× water immersion objective on a Zeiss LSM 780 confocal microscope. To stimulate Hcrt neurons, a region of interest (ROI) that encompassed the Hcrt neuron soma was illuminated using a 488 nm laser at 100% power. Ten pulses lasting 0.3 s each were applied over 3.2 s using the bleaching function, and then a ROI encompassing a GCaMP6s-expressing LC soma was imaged at 4 Hz for 30 s. The time between the final stimulation pulse and initiation of imaging was less than 0.1 s. This cycle of stimulation and imaging was repeated 8 times for each GCaMP6s-expressing soma. A baseline of 60 s was recorded before the first stimulation. Movies were processed using ImageJ (Schneider et al., 2012). The mean fluorescence of each LC neuron was measured by drawing a ROI around the soma. Baseline fluorescence (Fo) for each trial was defined as 10 frames immediately preceding the stimulation, and 10 frames post stimulation (F) were used to measure the total change in fluorescence (∆F/Fo = (F−Fo)/ Fo).

References

    1. Borbely AA
    2. Tobler I
    (1996)
    Sleep regulation: relation to photoperiod, sleep duration, waking activity, and torpor
    Progress in Brain Research 111:343–348.
    1. Born J
    2. Kellner C
    3. Uthgenannt D
    4. Kern W
    5. Fehm HL
    (1992)
    Vasopressin regulates human sleep by reducing rapid-eye-movement sleep
    The American Journal of Physiology 262:E295–E300.
    1. Bourgin P
    2. Huitron-Resendiz S
    3. Spier AD
    4. Fabre V
    5. Morte B
    6. Criado JR
    7. Sutcliffe JG
    8. Henriksen SJ
    9. de Lecea L
    (2000)
    Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons
    The Journal of Neuroscience 20:7760–7765.
    1. Chou TC
    2. Lee CE
    3. Lu J
    4. Elmquist JK
    5. Hara J
    6. Willie JT
    7. Beuckmann CT
    8. Chemelli RM
    9. Sakurai T
    10. Yanagisawa M
    11. Saper CB
    12. Scammell TE
    (2001)
    Orexin (hypocretin) neurons contain dynorphin
    The Journal of Neuroscience 21:RC168.
    1. Hunsley MS
    2. Palmiter RD
    (2003)
    Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine
    Sleep 26:521–526.
    1. Nagel G
    2. Brauner M
    3. Liewald JF
    4. Adeishvili N
    5. Bamberg E
    6. Gottschalk A
    (2005)
    Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses
    Current Biology 15:2279–2284.
    1. Peyron C
    2. Tighe DK
    3. van den Pol AN
    4. de Lecea L
    5. Heller HC
    6. Sutcliffe JG
    7. Kilduff TS
    (1998)
    Neurons containing hypocretin (orexin) project to multiple neuronal systems
    The Journal of Neuroscience 18:9996–10015.
    1. Westerfield M
    (2000)
    The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio)
    4th Edition, Eugene, OR, University of Oregon Press.

Article and author information

Author details

  1. Chanpreet Singh

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Contribution
    CS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Grigorios Oikonomou
    Competing interests
    The authors declare that no competing interests exist.

  2. Grigorios Oikonomou

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Contribution
    GO, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Chanpreet Singh
    Competing interests
    The authors declare that no competing interests exist.

  3. David A Prober

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Contribution
    DAP, Conception and design, Drafting or revising the article
    For correspondence
    dprober@caltech.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7371-4675

Funding

Rita Allen Foundation

  • David A Prober

Mallinckrodt Foundation

  • David A Prober

Brain and Behavior Research Foundation

  • David A Prober

National Institutes of Health (NIH) (F32 NS082010)

  • Grigorios Oikonomou

National Institutes of Health (NIH) (R00 NS060996)

  • David A Prober

National Institutes of Health (NIH) (R01 NS070911)

  • David A Prober

National Institutes of Health (NIH) (R01 DA031367)

  • David A Prober

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank Mike Walsh for assistance with the optogenetic and tapping assays, Andres Collazo for imaging assistance, Viveca Sapin and Jae Engle for genotyping assistance, David Schoppik, Alix Lacoste and Owen Randlett for tapping assay advice and Catherine Oikonomou for critical reading of the manuscript. This work was supported by grants from the NIH (GO: F32NS082010; DAP: NS060996, NS070911 and DA031367), the Mallinckrodt Foundation, the Rita Allen Foundation and the Brain and Behavior Research Foundation (DAP). We declare no competing interests.

Ethics

Animal experimentation: All experiments followed standard protocols (Westerfield, 2000) in accordance with the California Institute of Technology Institutional Animal Care and Use Committee guidelines.

Copyright

© 2015, Singh et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,648
    views
  • 698
    downloads
  • 103
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chanpreet Singh
  2. Grigorios Oikonomou
  3. David A Prober
(2015)
Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish
eLife 4:e07000.
https://doi.org/10.7554/eLife.07000

Share this article

https://doi.org/10.7554/eLife.07000

Categories and tags

Research organism

Further reading

    1. Neuroscience

    CaBP1 and 2 enable sustained CaV1.3 calcium currents and synaptic transmission in inner hair cells

    David Oestreicher, Shashank Chepurwar ... Tina Pangrsic
    Research Article

    To encode continuous sound stimuli, the inner hair cell (IHC) ribbon synapses utilize calcium-binding proteins (CaBPs), which reduce the inactivation of their CaV1.3 calcium channels. Mutations in the CABP2 gene underlie non-syndromic autosomal recessive hearing loss DFNB93. Besides CaBP2, the structurally related CaBP1 is highly abundant in the IHCs. Here, we investigated how the two CaBPs cooperatively regulate IHC synaptic function. In Cabp1/2 double-knockout mice, we find strongly enhanced CaV1.3 inactivation, slowed recovery from inactivation and impaired sustained exocytosis. Already mild IHC activation further reduces the availability of channels to trigger synaptic transmission and may effectively silence synapses. Spontaneous and sound-evoked responses of spiral ganglion neurons in vivo are strikingly reduced and strongly depend on stimulation rates. Transgenic expression of CaBP2 leads to substantial recovery of IHC synaptic function and hearing sensitivity. We conclude that CaBP1 and 2 act together to suppress voltage- and calcium-dependent inactivation of IHC CaV1.3 channels in order to support sufficient rate of exocytosis and enable fast, temporally precise and indefatigable sound encoding.

    1. Neuroscience

    A multisite validation of brain white matter pathways of resilience to chronic back pain

    Mina Mišić, Noah Lee ... Herta Flor
    Research Article

    Chronic back pain (CBP) is a global health concern with significant societal and economic burden. While various predictors of back pain chronicity have been proposed, including demographic and psychosocial factors, neuroimaging studies have pointed to brain characteristics as predictors of CBP. However, large-scale, multisite validation of these predictors is currently lacking. In two independent longitudinal studies, we examined white matter diffusion imaging data and pain characteristics in patients with subacute back pain (SBP) over 6- and 12-month periods. Diffusion data from individuals with CBP and healthy controls (HC) were analyzed for comparison. Whole-brain tract-based spatial statistics analyses revealed that a cluster in the right superior longitudinal fasciculus (SLF) tract had larger fractional anisotropy (FA) values in patients who recovered (SBPr) compared to those with persistent pain (SBPp), and predicted changes in pain severity. The SLF FA values accurately classified patients at baseline and follow-up in a third publicly available dataset (Area under the Receiver Operating Curve ~0.70). Notably, patients who recovered had FA values larger than those of HC suggesting a potential role of SLF integrity in resilience to CBP. Structural connectivity-based models also classified SBPp and SBPr patients from the three data sets (validation accuracy 67%). Our results validate the right SLF as a robust predictor of CBP development, with potential for clinical translation. Cognitive and behavioral processes dependent on the right SLF, such as proprioception and visuospatial attention, should be analyzed in subacute stages as they could prove important for back pain chronicity.

    1. Neuroscience

    The satiety hormone cholecystokinin gates reproduction in fish by controlling gonadotropin secretion

    Lian Hollander-Cohen, Omer Cohen ... Berta Levavi-Sivan
    Research Article

    Life histories of oviparous species dictate high metabolic investment in the process of gonadal development leading to ovulation. In vertebrates, these two distinct processes are controlled by the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH), respectively. While it was suggested that a common secretagogue, gonadotropin-releasing hormone (GnRH), oversees both functions, the generation of loss-of-function fish challenged this view. Here, we reveal that the satiety hormone cholecystokinin (CCK) is the primary regulator of this axis in zebrafish. We found that FSH cells express a CCK receptor, and our findings demonstrate that mutating this receptor results in a severe hindrance to ovarian development. Additionally, it causes a complete shutdown of both gonadotropins secretion. Using in-vivo and ex-vivo calcium imaging of gonadotrophs, we show that GnRH predominantly activates LH cells, whereas FSH cells respond to CCK stimulation, designating CCK as the bona fide FSH secretagogue. These findings indicate that the control of gametogenesis in fish was placed under different neural circuits, that are gated by CCK.